News

Filter

Current filters:

Pricing

26 to 35 of 1246 results

UK doctors call for approval of off-label use of Avastin for wet-AMD

UK doctors call for approval of off-label use of Avastin for wet-AMD

25-02-2015

Doctors in the UK are calling on health ministers and NHS England to intervene to make Swiss pharma giant…

AvastinBiotechnologyHealthcareLucentisNovartisOphthalmicsPricingRegulationRocheUK

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

25-02-2015

The UK’s National Institute for Health and Care Excellence has recommended Inlyta (axitinib), marketed…

DendreonInlytaOncologyPfizerPharmaceuticalPricingProvengeRegulationUKValeant Pharmaceuticals International

Access to medicines: evolving the European debate

Access to medicines: evolving the European debate

23-02-2015

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the debate…

EuropeHealthcarePharmaceuticalPoliticsPricing

IQWiG says Octapharma provided no suitable data on Nuwiq to show added benefit

IQWiG says Octapharma provided no suitable data on Nuwiq to show added benefit

20-02-2015

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined data on independent…

BiotechnologyGermanyHematologyNuwiqOctapharmaPricingRegulation

NICE gives green light to Bayer’s Eylea for DME

20-02-2015

In a preliminary recommendation issued today, England’s health costs watchdog the National Institute…

BayerEyleaOphthalmicsPharmaceuticalPricingRegulationUK

NICE sets too high a QALY cost for NHS drugs, new research claims

NICE sets too high a QALY cost for NHS drugs, new research claims

19-02-2015

The price the National Heath Service in England agrees to pay for new medicines is too high, causing…

HealthcarePharmaceuticalPricingUK

Effective new cholesterol treatments will come at great cost to health care system, says CVS

Effective new cholesterol treatments will come at great cost to health care system, says CVS

18-02-2015

The new class of cholesterol drugs could provide successful treatment to millions of Americans, but the…

BiotechnologyCVS HealthGastro-intestinalsMarkets & MarketingPricingUSA

Use of generics key to glaucoma medicine adherence, study says

Use of generics key to glaucoma medicine adherence, study says

18-02-2015

A potential solution to resolve patient non-adherence in glaucoma treatment is switching to generic drugs,…

Bimatoprost Ophthalmic Solution 0.03% for GlaLatanoprost OphthalmicOphthalmicsPharmaceuticalPricingResearchUSA

Pharma pricing regulation puts Spain 15% lower than Eurozone average

Pharma pricing regulation puts Spain 15% lower than Eurozone average

16-02-2015

The average price per standard unit of medicine in Spain was 15% lower than the average of Eurozone countries…

EuropePharmaceuticalPharmaceutical industryPricingSpain

26 to 35 of 1246 results

Back to top